{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:42:29Z","timestamp":1792024949724,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Veterans Administration Health Service","award":["BX000207"],"award-info":[{"award-number":["BX000207"]}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA086862 (supplement 24S1 and 25S1) and R61\/R33AI169659"],"award-info":[{"award-number":["P30CA086862 (supplement 24S1 and 25S1) and R61\/R33AI169659"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15874-x","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:23:50Z","timestamp":1774052630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevated m6A RNA modifications associate with immune dysregulation and cancer in people with HIV-1"],"prefix":"10.1186","volume":"26","author":[{"given":"Tarun","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack T.","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"7","key":"15874_CR1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187\u2013200.","journal-title":"Cell"},{"issue":"1","key":"15874_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"15874_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm3785","volume":"15","author":"KD Meyer","year":"2014","unstructured":"Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15(5):313\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"15874_CR4","doi-asserted-by":"publisher","first-page":"e105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40(3):e105977.","journal-title":"EMBO J"},{"issue":"6","key":"15874_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"15874_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40164-022-00281-2","volume":"11","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu F, Chen W, Liao Z, Zhang W, Zhang B, et al. The importance of N6-methyladenosine modification in tumor immunity and immunotherapy. Exp Hematol Oncol. 2022;11(1):30.","journal-title":"Exp Hematol Oncol"},{"key":"15874_CR7","doi-asserted-by":"crossref","unstructured":"Phillips S, Mishra T, Huang S, Wu L. Functional impacts of epitranscriptomic m(6)A modification on HIV-1 infection. Viruses. 2024;16(1):127.","DOI":"10.3390\/v16010127"},{"key":"15874_CR8","doi-asserted-by":"crossref","unstructured":"Tirumuru N, Zhao BS, Lu W, Lu Z, He C, Wu L. N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression. eLife. 2016;5:e15528.","DOI":"10.7554\/eLife.15528"},{"key":"15874_CR9","doi-asserted-by":"publisher","first-page":"16011","DOI":"10.1038\/nmicrobiol.2016.11","volume":"1","author":"G Lichinchi","year":"2016","unstructured":"Lichinchi G, Gao S, Saletore Y, Gonzalez GM, Bansal V, Wang Y, et al. Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells. Nat Microbiol. 2016;1:16011.","journal-title":"Nat Microbiol"},{"issue":"34","key":"15874_CR10","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1074\/jbc.RA118.004215","volume":"293","author":"W Lu","year":"2018","unstructured":"Lu W, Tirumuru N, St Gelais C, Koneru PC, Liu C, Kvaratskhelia M, et al. N(6)-methyladenosine-binding proteins suppress HIV-1 infectivity and viral production. J Biol Chem. 2018;293(34):12992\u20133005.","journal-title":"J Biol Chem"},{"issue":"3","key":"15874_CR11","doi-asserted-by":"publisher","first-page":"e1009421","DOI":"10.1371\/journal.ppat.1009421","volume":"17","author":"S Chen","year":"2021","unstructured":"Chen S, Kumar S, Espada CE, Tirumuru N, Cahill MP, Hu L, et al. N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages. PLoS Pathog. 2021;17(3):e1009421.","journal-title":"PLoS Pathog"},{"issue":"11","key":"15874_CR12","doi-asserted-by":"publisher","first-page":"e0221424","DOI":"10.1128\/mbio.02214-24","volume":"15","author":"T Mishra","year":"2024","unstructured":"Mishra T, Phillips S, Zhao Y, Wilms B, He C, Wu L. Epitranscriptomic m(6)A modifications during reactivation of HIV-1 latency in CD4(+) T cells. mBio. 2024;15(11):e0221424.","journal-title":"mBio"},{"issue":"9","key":"15874_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/aid.2024.0003","volume":"40","author":"T Mishra","year":"2024","unstructured":"Mishra T, Phillips S, Maldonado C, Stapleton JT, Wu L. Antiretroviral therapy suppresses RNA N(6)-methyladenosine modification in peripheral blood mononuclear cells from HIV-1-infected individuals. AIDS Res Hum Retroviruses. 2024;40(9):511\u201320.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"15874_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jnci\/djr076","volume":"103","author":"MS Shiels","year":"2011","unstructured":"Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753\u201362.","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"15874_CR15","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/QAD.0b013e32835935b3","volume":"26","author":"C Chao","year":"2012","unstructured":"Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, et al. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS. 2012;26(17):2223\u201331.","journal-title":"AIDS"},{"issue":"11","key":"15874_CR16","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hernandez-Ramirez","year":"2017","unstructured":"Hernandez-Ramirez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495\u2013504.","journal-title":"Lancet HIV"},{"issue":"3","key":"15874_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335\u201345.","journal-title":"Mol Cell"},{"issue":"2","key":"15874_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell. 2018;22(2):191\u2013205. e199.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"15874_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","volume":"25","author":"J Paris","year":"2019","unstructured":"Paris J, Morgan M, Campos J, Spencer GJ, Shmakova A, Ivanova I, et al. Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell. 2019;25(1):137\u2013e148136.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"15874_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41590-019-0314-4","volume":"20","author":"R Winkler","year":"2019","unstructured":"Winkler R, Gillis E, Lasman L, Safra M, Geula S, Soyris C, et al. Publisher correction: m6A modification controls the innate immune response to infection by targeting type I interferons. Nat Immunol. 2019;20(2):243.","journal-title":"Nat Immunol"},{"key":"15874_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-0716-3862-0_14","volume":"2807","author":"T Mishra","year":"2024","unstructured":"Mishra T, Phillips S, Wu L. Method for the enrichment of N(6)-methyladenosine-modified cellular and HIV-1 RNA. Methods Mol Biol. 2024;2807:195\u2013208.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"15874_CR22","doi-asserted-by":"publisher","first-page":"e0042525","DOI":"10.1128\/mbio.00425-25","volume":"16","author":"H Yang","year":"2025","unstructured":"Yang H, Cheung PH, Wu L. SAMHD1 enhances HIV-1-induced apoptosis in monocytic cells via the mitochondrial pathway. mBio. 2025;16(7):e0042525.","journal-title":"mBio"},{"issue":"9","key":"15874_CR23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1001\/jamadermatol.2017.1716","volume":"153","author":"MM Asgari","year":"2017","unstructured":"Asgari MM, Ray GT, Quesenberry CP Jr., Katz KA, Silverberg MJ. Association of multiple primary skin cancers with human immunodeficiency virus infection, CD4 count, and viral load. JAMA Dermatol. 2017;153(9):892\u20136.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"15874_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/QAI.0000000000003452","volume":"96","author":"IA Nicolau","year":"2024","unstructured":"Nicolau IA, Moineddin R, Brooks JD, Antoniou T, Gillis JL, Kendall CE, et al. Associations of CD4 Cell Count Measures With Infection-Related and Infection-Unrelated Cancer Risk Among People With HIV. J Acquir Immune Defic Syndr. 2024;96(5):447\u201356.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"15874_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s43587-023-00393-2","volume":"3","author":"Z Wu","year":"2023","unstructured":"Wu Z, Lu M, Liu D, Shi Y, Ren J, Wang S, et al. m(6)A epitranscriptomic regulation of tissue homeostasis during primate aging. Nat Aging. 2023;3(6):705\u201321.","journal-title":"Nat Aging"},{"issue":"10","key":"15874_CR26","doi-asserted-by":"publisher","first-page":"e13972","DOI":"10.1111\/acel.13972","volume":"22","author":"Z Wu","year":"2023","unstructured":"Wu Z, Ren J, Liu GH. Deciphering RNA m(6) A regulation in aging: Perspectives on current advances and future directions. Aging Cell. 2023;22(10):e13972.","journal-title":"Aging Cell"},{"key":"15874_CR27","doi-asserted-by":"crossref","unstructured":"Cai S, Zhou J, Luo X, Zhang C, Jin S, Ren J, et al. Phase transition of WTAP regulates m6A modification of interferon-stimulated genes. eLife. 2025:RP100601.","DOI":"10.7554\/eLife.100601.2"},{"issue":"2","key":"15874_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41568-025-00889-6","volume":"26","author":"H Luo","year":"2026","unstructured":"Luo H, Kharas MG, Jaffrey SR. N(6)-Methyladenosine: an RNA modification as a central regulator of cancer. Nat Rev Cancer. 2026;26(2):118\u201336.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"15874_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41420-024-02092-2","volume":"10","author":"X Han","year":"2024","unstructured":"Han X, Zhu Y, Ke J, Zhai Y, Huang M, Zhang X, et al. Progression of m(6)A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming. Cell Death Discov. 2024;10(1):331.","journal-title":"Cell Death Discov"},{"issue":"6","key":"15874_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41568-018-0002-y","volume":"18","author":"PM Comoglio","year":"2018","unstructured":"Comoglio PM, Trusolino L, Boccaccio C. Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. Nat Rev Cancer. 2018;18(6):341\u201358.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"15874_CR31","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2015-07-658823","volume":"126","author":"L Dai","year":"2015","unstructured":"Dai L, Trillo-Tinoco J, Cao Y, Bonstaff K, Doyle L, Del Valle L, et al. Targeting HGF\/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma. Blood. 2015;126(26):2821\u201331.","journal-title":"Blood"},{"issue":"11","key":"15874_CR32","doi-asserted-by":"publisher","first-page":"e0135624","DOI":"10.1128\/jvi.01356-24","volume":"98","author":"WQ He","year":"2024","unstructured":"He WQ, Pang W, Li N, Li AQ, Li YH, Lu Y, et al. IFI27 inhibits HIV-1 replication by degrading gag protein through the ubiquitin-proteasome pathway. J Virol. 2024;98(11):e0135624.","journal-title":"J Virol"},{"issue":"1","key":"15874_CR33","doi-asserted-by":"publisher","first-page":"8515","DOI":"10.1080\/21655979.2021.1985858","volume":"12","author":"S Huang","year":"2021","unstructured":"Huang S, Zhao J, Song J, Li Y, Zuo R, Sa Y, et al. Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis. Bioengineered. 2021;12(1):8515\u201328.","journal-title":"Bioengineered"},{"issue":"7344","key":"15874_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481\u20135.","journal-title":"Nature"},{"key":"15874_CR35","doi-asserted-by":"crossref","unstructured":"Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11(3):200.","DOI":"10.3390\/v11030200"},{"issue":"1","key":"15874_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12935-024-03289-2","volume":"24","author":"C Zhang","year":"2024","unstructured":"Zhang C, Chen J, Ren J, Li X, Zhang Y, Huang B, et al. N(6)-methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer. Cancer Cell Int. 2024;24(1):96.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"15874_CR37","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1074\/jbc.RA118.005608","volume":"294","author":"N Tirumuru","year":"2019","unstructured":"Tirumuru N, Wu L. HIV-1 envelope proteins up-regulate N(6)-methyladenosine levels of cellular RNA independently of viral replication. J Biol Chem. 2019;294(9):3249\u201360.","journal-title":"J Biol Chem"},{"issue":"3","key":"15874_CR38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4049\/jimmunol.1900856","volume":"204","author":"S Rinaldi","year":"2020","unstructured":"Rinaldi S, Pallikkuth S, Cameron M, de Armas LR, Cotugno N, Dinh V, et al. Impact of early antiretroviral therapy initiation on HIV-specific CD4 and CD8 T cell function in perinatally infected children. J Immunol. 2020;204(3):540\u20139.","journal-title":"J Immunol"},{"issue":"3","key":"15874_CR39","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","volume":"103","author":"S Franceschi","year":"2010","unstructured":"Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103(3):416\u201322.","journal-title":"Br J Cancer"},{"key":"15874_CR40","doi-asserted-by":"crossref","unstructured":"Omar A, Marques N, Crawford N. Cancer and HIV: The molecular mechanisms of the deadly duo. Cancers (Basel). 2024;16(3):546.","DOI":"10.3390\/cancers16030546"},{"issue":"2","key":"15874_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177\u201389.","journal-title":"Cell Res"},{"key":"15874_CR42","doi-asserted-by":"publisher","first-page":"635329","DOI":"10.3389\/fonc.2021.635329","volume":"11","author":"XY Dai","year":"2021","unstructured":"Dai XY, Shi L, Li Z, Yang HY, Wei JF, Ding Q. Main N6-methyladenosine readers: YTH family proteins in cancers. Front Oncol. 2021;11:635329.","journal-title":"Front Oncol"},{"issue":"3","key":"15874_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A Modification in Coding and Non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270\u201388.","journal-title":"Cancer Cell"},{"issue":"12","key":"15874_CR44","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.molcel.2022.05.029","volume":"82","author":"S Murakami","year":"2022","unstructured":"Murakami S, Jaffrey SR. Hidden codes in mRNA: Control of gene expression by m(6)A. Mol Cell. 2022;82(12):2236\u201351.","journal-title":"Mol Cell"},{"issue":"7","key":"15874_CR45","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara S, Jaffrey SR. A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA. Cell. 2020;181(7):1582\u201395. e1518.","journal-title":"Cell"},{"issue":"7","key":"15874_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tibs.2024.04.001","volume":"49","author":"Z Zou","year":"2024","unstructured":"Zou Z, He C. The YTHDF proteins display distinct cellular functions on m(6)A-modified RNA. Trends Biochem Sci. 2024;49(7):611\u201321.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"15874_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41420-022-00947-0","volume":"8","author":"J Liao","year":"2022","unstructured":"Liao J, Wei Y, Liang J, Wen J, Chen X, Zhang B, et al. Insight into the structure, physiological function, and role in cancer of m6A readers-YTH domain-containing proteins. Cell Death Discov. 2022;8(1):137.","journal-title":"Cell Death Discov"},{"issue":"11","key":"15874_CR48","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/s12276-025-01587-x","volume":"57","author":"S Lu","year":"2025","unstructured":"Lu S, Wei X, Zhu H, Li L, Zhang W, Du P, et al. RNA N(6)-methyladenosine reader protein YTHDF1 promotes plasma cell differentiation via IRF4 regulation in systemic lupus erythematosus. Exp Mol Med. 2025;57(11):2574\u201387.","journal-title":"Exp Mol Med"},{"issue":"1","key":"15874_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12967-021-02918-y","volume":"19","author":"C Liu","year":"2021","unstructured":"Liu C, Yang Z, Li R, Wu Y, Chi M, Gao S, et al. Potential roles of N6-methyladenosine (m6A) in immune cells. J Transl Med. 2021;19(1):251.","journal-title":"J Transl Med"},{"issue":"10","key":"15874_CR50","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1093\/nar\/gky156","volume":"46","author":"Y Du","year":"2018","unstructured":"Du Y, Hou G, Zhang H, Dou J, He J, Guo Y, et al. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function. Nucleic Acids Res. 2018;46(10):5195\u2013208.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"15874_CR51","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1093\/nar\/gkab415","volume":"49","author":"F Yu","year":"2021","unstructured":"Yu F, Wei J, Cui X, Yu C, Ni W, Bungert J, et al. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response. Nucleic Acids Res. 2021;49(10):5779\u201397.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"15874_CR52","doi-asserted-by":"publisher","first-page":"106454","DOI":"10.1016\/j.isci.2023.106454","volume":"26","author":"RD Mackelprang","year":"2023","unstructured":"Mackelprang RD, Filali-Mouhim A, Richardson B, Lefebvre F, Katabira E, Ronald A, et al. Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection. iScience. 2023;26(4):106454.","journal-title":"iScience"},{"key":"15874_CR53","doi-asserted-by":"crossref","unstructured":"Ji M, Ganesan S, Xia B, Huo Y. Targeting c-MET alterations in cancer: a review of genetic drivers and therapeutic implications. Cancers (Basel). 2025;17(9):1493.","DOI":"10.3390\/cancers17091493"},{"issue":"2","key":"15874_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cytogfr.2012.09.001","volume":"24","author":"P Ataie-Kachoie","year":"2013","unstructured":"Ataie-Kachoie P, Pourgholami MH, Morris DL. Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev. 2013;24(2):163\u201373.","journal-title":"Cytokine Growth Factor Rev"},{"key":"15874_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cyto.2015.11.011","volume":"89","author":"K Meissl","year":"2017","unstructured":"Meissl K, Macho-Maschler S, Muller M, Strobl B. The good and the bad faces of STAT1 in solid tumours. Cytokine. 2017;89:12\u201320.","journal-title":"Cytokine"},{"issue":"13","key":"15874_CR56","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.18632\/oncotarget.7626","volume":"7","author":"RH Chen","year":"2016","unstructured":"Chen RH, Du Y, Han P, Wang HB, Liang FY, Feng GK, et al. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma. Oncotarget. 2016;7(13):16910\u201322.","journal-title":"Oncotarget"},{"issue":"1","key":"15874_CR57","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/07853890.2021.1995624","volume":"54","author":"H Huang","year":"2022","unstructured":"Huang H, Lv J, Huang Y, Mo Z, Xu H, Huang Y, et al. IFI27 is a potential therapeutic target for HIV infection. Ann Med. 2022;54(1):314\u201325.","journal-title":"Ann Med"},{"issue":"9","key":"15874_CR58","doi-asserted-by":"publisher","first-page":"108798","DOI":"10.1016\/j.celrep.2021.108798","volume":"34","author":"MJ McFadden","year":"2021","unstructured":"McFadden MJ, McIntyre ABR, Mourelatos H, Abell NS, Gokhale NS, Ipas H, et al. Post-transcriptional regulation of antiviral gene expression by N6-methyladenosine. Cell Rep. 2021;34(9):108798.","journal-title":"Cell Rep"},{"issue":"1","key":"15874_CR59","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41467-021-25803-0","volume":"12","author":"H Song","year":"2021","unstructured":"Song H, Song J, Cheng M, Zheng M, Wang T, Tian S, et al. METTL3-mediated m(6)A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nat Commun. 2021;12(1):5522.","journal-title":"Nat Commun"},{"issue":"10","key":"15874_CR60","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","volume":"13","author":"AA Guirguis","year":"2023","unstructured":"Guirguis AA, Ofir-Rosenfeld Y, Knezevic K, Blackaby W, Hardick D, Chan YC, et al. Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity. Cancer Discov. 2023;13(10):2228\u201347.","journal-title":"Cancer Discov"},{"key":"15874_CR61","doi-asserted-by":"crossref","unstructured":"Carmona-Perez L, Dagenais-Lussier X, Mai LT, Stogerer T, Swaminathan S, Isnard S, et al. The TLR7\/IRF-5 axis sensitizes memory CD4\u2009+\u2009T cells to fas-mediated apoptosis during HIV-1 infection. JCI Insight. 2023;8(13):e167329.","DOI":"10.1172\/jci.insight.167329"},{"key":"15874_CR62","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.3389\/fimmu.2019.02388","volume":"10","author":"Z Urban-Wojciuk","year":"2019","unstructured":"Urban-Wojciuk Z, Khan MM, Oyler BL, Fahraeus R, Marek-Trzonkowska N, Nita-Lazar A, et al. The Role of TLRs in Anti-cancer immunity and tumor rejection. Front Immunol. 2019;10:2388.","journal-title":"Front Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15874-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:03:00Z","timestamp":1776920580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15874"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15874-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8070380\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study using human PBMCs from PLWH with or without cancer and consent to participate have been approved by the Institutional Review Board (IRB) of the University of Iowa. Individuals attending the University of Iowa Virology Clinic were invited to participate in this study and, following written informed consent, provided blood samples. The informed consent to participate was obtained from all of the participants in the study. The study was conducted according to the Declaration of Helsinki guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication has been obtained from the study participants through the approved IRB protocol as described above. Only de-identified information is shown in the sample summary Tables\u00a0\n                      \n                      and\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"516"}}